<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">

Neural Connections Blog

MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions

In Vitro Modeling

The goal of the preclinical development process is to help predict clinical efficacy, emphasizing the importance of studying diseases through models that yield predictive and clinically relevant data. This involves using both in vivo and in vitro approaches to understand the complexities of human diseases. In vitro models provide valuable insights into the mechanisms of action, while in vivo models offer translational outcomes.

The HTX-011 Story

HTX-011 Breakthrough in Pain Management

ZYNRELEF, the commercial name for HTX-011, is the first and...

Wound Healing Models in Pigs

It is important to bridge the gap between lab findings and clinical applications using...

Advancing Nerve Injury and Repair Models

Understanding Mechanisms Underlying Neuropathic Pain

Porcine Translational Research

Advancing Beyond Rodent and Non-Human Primate Models

While rodent models have contributed...

Increase diversity to improve clinical translation and strengthen pain management outcomes.

The goal of preclinical drug development is to identify potential therapeutic compounds and gain an...

New Publication - A novel sensory wave (p25) in MOG-EAE model

MD Biosciences has published a new article in the Journal of Pain describing a novel sensory wave...

Three ways to approach translation

As the general population continues to age, the economic burden of chronic pain and...